Alphatec Holdings (ATEC) Net Income towards Common Stockholders (2010 - 2026)
Alphatec Holdings (ATEC) posted Net Income towards Common Stockholders of -$33.9 million for Q1 2026, down 56.04% sequentially from -$21.7 million in Q4 2025, and up 34.68% YoY from -$25.2 million in Q1 2025.
Alphatec Holdings (ATEC) Net Income towards Common Stockholders (2010 - 2026) Analysis & Trends
Alphatec Holdings has reported Net Income towards Common Stockholders for 17 years, with the latest figure at -$33.9 million in Q1 2026.
- Quarterly Net Income towards Common Stockholders rose 34.68% year-over-year to -$33.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$125.4 million (up 24.27% YoY) and the FY2025 annual result came in at -$143.4 million, up 11.57% from the prior year.
- Net Income towards Common Stockholders eased to -$33.9 million in Q1 2026 per ATEC's latest filing, from -$21.7 million in the prior quarter.
- Over five years, Net Income towards Common Stockholders peaked at -$21.7 million in Q4 2025 and troughed at -$51.9 million in Q1 2025.
- A 5-year average of -$39.8 million and a median of -$40.7 million in 2024 frame the typical range for Net Income towards Common Stockholders.
- The sharpest annual moves came in 2022 and 2025: Net Income towards Common Stockholders sank 86.07% in 2022, then soared 34.81% in 2025.
- Over 5 years, Net Income towards Common Stockholders stood at -$34.8 million in 2022, then tumbled by 41.1% to -$49.1 million in 2023, then jumped by 32.08% to -$33.3 million in 2024, then jumped by 34.81% to -$21.7 million in 2025, then sank by 56.04% to -$33.9 million in 2026.
- According to Business Quant data, Net Income towards Common Stockholders over the past three periods registered -$33.9 million, -$21.7 million, and -$28.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn | 907.00 Mn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 621.86 Mn |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Alphatec Holdings | 1.46 Bn | 1.34 Bn | 154.10 Mn | -25.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -25.78 Mn |
| Mar 31, 2026 | -33.91 Mn |
| Dec 31, 2025 | -21.73 Mn |
| Sep 30, 2025 | -28.58 Mn |
| Jun 30, 2025 | -41.14 Mn |
| Mar 31, 2025 | -51.91 Mn |
| Dec 31, 2024 | -33.33 Mn |
| Sep 30, 2024 | -39.62 Mn |
| Jun 30, 2024 | -40.68 Mn |
| Mar 31, 2024 | -48.50 Mn |
| Dec 31, 2023 | -49.08 Mn |
| Sep 30, 2023 | -42.65 Mn |
| Jun 30, 2023 | -51.38 Mn |
| Mar 31, 2023 | -43.53 Mn |
| Dec 31, 2022 | -34.78 Mn |
| Sep 30, 2022 | -36.79 Mn |
| Jun 30, 2022 | -37.10 Mn |
| Mar 31, 2022 | -42.62 Mn |
| Dec 31, 2021 | -38.89 Mn |
| Sep 30, 2021 | -43.03 Mn |